Musculoskeletal disease likely a risk factor for development of dementias
1. Participants reporting a greater number of chronic pain sites had a higher proportion of developing incident all-cause dementia, AD, ...
Tag: Alzheimer’s disease
Retinal optical coherence tomography (OCT) measurements may be associated with genetic Alzheimer’s disease risk
1. In a retrospective study examining 50,000 optical coherence tomography (OCT) images from a large database, thicknesses of several different ...
Wellness Check: Sleep
Prior COVID-19 infection may result in poorer sleep health 1. In this cross-sectional study, it was found that participants had ...
The 2 Minute Medicine Podcast Episode 6
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo
1. Lecanemab was associated with reduced amyloid markers in early Alzheimer’s disease as compared to placebo. 2. Lecanemab also resulted ...
Lecanemab may slow cognitive decline in early Alzheimer’s disease
1. Lecanemab was associated with reduced amyloid markers in early Alzheimer’s disease as compared to placebo. 2. Lecanemab also resulted ...
The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Spirituality may aid patients with neurological diseases cope with their illness
1. In patients with neurological disorders, spirituality appeared to be associated with a higher quality of life and emotional wellbeing. ...
Wellness Check: Spirituality
The experience of spirituality may positively impact the lives of terminal cancer patients 1. In this study, individuals were found ...
Plasma p-tau217 is an accurate plasma biomarker of pathologic cerebral changes in patients with Down Syndrome
1. Plasma biomarkers, including p-tau217, were found to accurately detect cerebral changes pathognomonic for Alzheimer’s disease in this cross-sectional, multicenter ...